Efficacy of Unani Formulation in Headache (Migraine)

Efficacy of Tila (Liniment) application in pain and disability Management of Shaqiqa-i-Muzmin (Chronic Migraine)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041868

Enrollment

Registered

2022-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura

Interventions

Intervention1: Unani Formulation in the form of Tila (Liniment) Containing Euphorbia resinifera Berg. Ferula foetida Ferula galbaniflua and Sugar cane vinegar. : Tila applied on most painful site of

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed Patients with chronic migraine as per ICHD criteria12 Patients between 18 â??60 years of age Either gender Willing to fill daily headache diary Willing to sign written informed consent

Exclusion criteria

Exclusion criteria: Patients below 18 and above 60 years of age Non-migrainous headache: tension-type headache, cluster headache, chronic paroxysmal or non-paroxysmal hemicranias Familial hemiplegic migraine Pregnancy and Lactation Patients with Neuropsychiatric illness Patients with significant co-morbidity

Design outcomes

Primary

Measure	Time frame
Improvement in Visual Analogue scale (VAS). Timepoint: 90 days	—

Secondary

Measure	Time frame
Improvement in Migraine disability assessment scale (MIDAS).Timepoint: 90 days	—

Countries

India

Contacts

Public ContactProf Abdul Nasir Ansari

NATIONAL INSTITUTE OF UNANI MEDICINE BANGALORE

abdulnasiransari@gmail.com9379165162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026